Kathryn Phillips, PhD
|Kennedy School of Government Harvard University||MC-MPA|
|University of Texas at Austin||BA|
|Harvard/Dept of Navy (civilian)||1985
||1986||Training Award for mid-career Master's Degree|
||1988||UC Berkeley Graduate Fellowship|
||1989||Outstanding Graduate Student Instructor|
|Am J Prev Med||1999
||1999||Commendation for outstanding journal reviews|
|Univ of CT||2003
||2003||50 Most Cited HIV Behavioral Researchers in Past Decade|
|Research Triangle Institute||2010
||2010||Most cited article award|
|Bellagio Center Italy||2016||Rockefeller Foundation Residency|
Kathryn A. Phillips, PhD, a health services researcher and health economist and leader in the application of new technologies to improve healthcare, is the founding director of the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) in the School of Pharmacy at the University of California, San Francisco (UCSF). She is also a professor of health economics and health services research in the Department of Clinical Pharmacy at UCSF, with additional appointments in the UCSF Philip R. Lee Institute for Health Policy Studies and UCSF Helen Diller Family Comprehensive Cancer Center
Kathryn focuses on the value of new technologies and how to most effectively and efficiently implement them into health care. Her core specialty is personalized (or precision) medicine — a new era of healthcare where medical interventions can be tailored to individual patients based on their unique genetic make-up. Her work spans multiple disciplines, including basic, clinical and social sciences, and brings together leading experts in academia, industry, healthcare, payers, and government. Kathryn led one of the earliest studies on the societal implications of pharmacogenomics, underscoring its potential to reduce the incidence of adverse drug reactions (JAMA, 2001). Her pioneering research on the application of health services research to personalized medicine has revealed insights on how to bridge the gap between emerging technologies and their use in the clinic. Kathryn has also conducted seminal work on HIV, as her analysis of HIV home testing informed the FDA’s decision to approve the first home collection HIV test (New England Journal of Medicine, 1995).
Kathryn has published more than 100 peer-reviewed articles in major journals, including JAMA, the New England Journal of Medicine, and Health Affairs and has had continuous funding from the US. National Institutes of Health as a principal investigator for 25 years. She currently serves on the editorial boards of the journal Health Affairs (rated as the top policy journal) and several leading journals on personalized medicine. Kathryn has served on national and international scientific advisory committees and workshops including work for GenomeCanada, Institutes of Medicine, Food and Drug Administration, Centers for Disease Control and Prevention, and the President’s Council of Advisors on Science and Technology. She has also served as an advisor to various international and industry organizations, including more than 35 biotechnology companies and venture capital firms. Most recently, she has been asked by the Patient-Centered Outcomes Research Institute (PCORI) - the largest funder of comparative effectiveness research in the world - to develop potential topics for their research agenda on personalized/precision medicine.
Health services research, health economics, policy analysis, personalized/precision medicine, value of diagnostics, population screening, utilization and cost–effectiveness of care, coverage/reimbursement policies, cancer, creating a high value health care system, cost–effectiveness analysis, secondary dataset analysis, systematic literature review, comparative effectiveness research, quantitative preference measurement, women’s reproductive health
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.